The influence of continuous renal replacement therapy on 1,3-β-d-glucan levels in critically ill patients: a single-center retrospective propensity score study
Abstract1,3-β-d-Glucan (BDG) is commonly used for diagnosing invasive fungal infections (IFIs). While exposure to cellulose-based hemodialyzers is known to cause false-positive BDG results, the impact of modern hemofilters used in continuous renal replacement therapy (CRRT) remains unclear. This ret...
Main Authors: | M. Gabriela Cabanilla, Matthew J. Briski, Zachary Bruss, Lisa Saa, Pamela C. Vasquez, Chelsea N. Rodriguez, Jessica A. Mitchell, Michael L. Bernauer, Christos P. Argyropoulos, Cameron S. Crandall, J. Pedro Teixeira |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2023.2255680 |
Similar Items
-
Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data
by: Laura Ferreras-Antolin, et al.
Published: (2022-11-01) -
The Comparative Evaluation of the Fujifilm Wako β-Glucan Assay and Fungitell Assay for Diagnosing Invasive Fungal Disease
by: Shreya Singh, et al.
Published: (2022-12-01) -
Beta-D-Glucan in Patients with Haematological Malignancies
by: Malgorzata Mikulska, et al.
Published: (2021-12-01) -
Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review
by: Afzal Azim, et al.
Published: (2024-03-01) -
Clinical value of blood circulating (1→3)β-D-glucan in patients with suspected invasive fungal infection
by: V. P. Pirumovav, et al.
Published: (2014-07-01)